PARP14
Basic information
Region (hg38): 3:122680839-122730840
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (170 variants)
- not_provided (5 variants)
- Abnormality_of_neuronal_migration (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PARP14 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000017554.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | |||||
| missense | 150 | 20 | 175 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 150 | 20 | 6 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PARP14 | protein_coding | protein_coding | ENST00000474629 | 17 | 50223 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.00674 | 0.993 | 124623 | 0 | 28 | 124651 | 0.000112 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.63 | 698 | 922 | 0.757 | 0.0000466 | 11864 |
| Missense in Polyphen | 133 | 251.5 | 0.52882 | 3374 | ||
| Synonymous | 0.663 | 339 | 355 | 0.955 | 0.0000189 | 3389 |
| Loss of Function | 5.59 | 18 | 67.6 | 0.266 | 0.00000325 | 949 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000284 | 0.000276 |
| Ashkenazi Jewish | 0.000105 | 0.0000994 |
| East Asian | 0.000111 | 0.000111 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000144 | 0.000142 |
| Middle Eastern | 0.000111 | 0.000111 |
| South Asian | 0.0000691 | 0.0000654 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: ADP-ribosyltransferase (PubMed:16061477, PubMed:27796300). By mono-ADP-ribosylating STAT1 at 'Glu-657' and 'Glu-705' and thus decreasing STAT1 phosphorylation, negatively regulates pro-inflammatory cytokines production in macrophages in response to IFNG stimulation (PubMed:27796300). Mono-ADP- ribosylates STAT6 (By similarity). Enhances STAT6-dependent transcription (By similarity). In macrophages, positively regulates MRC1 expression in response to IL4 stimulation by promoting STAT6 phosphorylation (PubMed:27796300). Mono-ADP- ribosylates PARP9 (PubMed:27796300). {ECO:0000250|UniProtKB:Q2EMV9, ECO:0000269|PubMed:16061477, ECO:0000269|PubMed:27796300}.;
- Pathway
- IL4-mediated signaling events
(Consensus)
Recessive Scores
- pRec
- 0.0851
Intolerance Scores
- loftool
- 0.658
- rvis_EVS
- -0.55
- rvis_percentile_EVS
- 20.02
Haploinsufficiency Scores
- pHI
- 0.105
- hipred
- N
- hipred_score
- 0.259
- ghis
- 0.502
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.590
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Parp14
- Phenotype
- immune system phenotype; cellular phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- protein ADP-ribosylation;negative regulation of gene expression;positive regulation of tyrosine phosphorylation of STAT protein;negative regulation of tyrosine phosphorylation of STAT protein;innate immune response;negative regulation of interferon-gamma-mediated signaling pathway;positive regulation of interleukin-4-mediated signaling pathway
- Cellular component
- nucleus;cytoplasm;cytosol;membrane
- Molecular function
- NAD+ ADP-ribosyltransferase activity;protein binding;enzyme binding